Does CAPMATINIB Cause Decreased appetite? 95 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 95 reports of Decreased appetite have been filed in association with CAPMATINIB (TABRECTA). This represents 4.1% of all adverse event reports for CAPMATINIB.
95
Reports of Decreased appetite with CAPMATINIB
4.1%
of all CAPMATINIB reports
16
Deaths
30
Hospitalizations
How Dangerous Is Decreased appetite From CAPMATINIB?
Of the 95 reports, 16 (16.8%) resulted in death, 30 (31.6%) required hospitalization, and 2 (2.1%) were considered life-threatening.
Is Decreased appetite Listed in the Official Label?
Yes, Decreased appetite is listed as a known adverse reaction in the official FDA drug label for CAPMATINIB.
What Other Side Effects Does CAPMATINIB Cause?
Death (411)
Peripheral swelling (283)
Fatigue (257)
Oedema peripheral (247)
Nausea (240)
Malignant neoplasm progression (178)
Dyspnoea (141)
Oedema (130)
Asthenia (113)
Non-small cell lung cancer (96)
What Other Drugs Cause Decreased appetite?
ADALIMUMAB (6,135)
LENALIDOMIDE (5,103)
SEMAGLUTIDE (4,317)
METHOTREXATE (4,229)
CABOZANTINIB S-MALATE (4,076)
APREMILAST (3,442)
RITUXIMAB (3,438)
PALBOCICLIB (3,400)
PREDNISONE (3,390)
LENVATINIB (3,257)
Which CAPMATINIB Alternatives Have Lower Decreased appetite Risk?
CAPMATINIB vs CAPREOMYCIN
CAPMATINIB vs CAPSAICIN
CAPMATINIB vs CAPTOPRIL
CAPMATINIB vs CARBAMAZEPINE
CAPMATINIB vs CARBETOCIN